SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network is trending due to a recent AI-related partnership and exceptionally high short interest, sparking intense speculation among traders. The community is actively debating the potential for a substantial short squeeze, drawing comparisons to historical parabolic runs, as investors weigh the dramatic upward momentum against the risks of a significant pullback.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending due to reports of a substantial government investment, acquiring an equity stake and providing significant financing to bolster domestic critical mineral production for national security. This development has sparked highly bullish sentiment among the community, with many anticipating substantial price gains and a short squeeze, while also prompting discussions around valuation and market influences within the rare earth sector.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is experiencing a dramatic rally, with community chatter centered on a significant short squeeze and a re-evaluation of silver as a hard asset amid concerns about currency devaluation and economic stability. Euphoric bulls are pushing for higher prices, citing industrial demand and historical suppression, while bears anticipate an imminent "blow off top" and a sharp correction as profit-taking looms.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending following its U.S. subsidiary's submission of a consolidated deep-seabed mining application to NOAA, a move that significantly expands its potential recovery area and streamlines the permitting process. This development, coupled with broader U.S. government focus on securing critical mineral supply chains, has ignited extremely bullish sentiment within the community. Investors are actively discussing the likelihood of swift permit approval and anticipating substantial upside driven by national security implications and the urgency to reduce reliance on foreign mineral sources.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune (ALT) is currently trending as community optimism grows following its Breakthrough Therapy Designation for MASH, positioning its drug, Pemvidutide, as a de-risked and highly attractive asset. Discussions are heating up around a potential partnership or major buyout, driven by Pemvidutide's 'best-in-class' profile in the burgeoning MASH and obesity markets, amidst notable trading volume and short squeeze speculation.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending significantly as gold prices approach historical highs, largely fueled by escalating geopolitical tensions and widespread concerns over the dollar's stability. The community is actively debating whether this surge reflects genuine safe-haven demand and central bank accumulation or if it signals an overextended market ripe for a correction. Amidst calls for continued buying and warnings of a bubble, many view gold as an essential hedge in an uncertain global economic and political landscape.

Skywater Technology, Inc. is a holding company. It engages in the provision of semiconductor development, manufacturing services, and packaging services. The company was founded on October 3, 2016 and is headquartered in Bloomington, MN.

SkyWater Technology Inc

SkyWater Technology is a major talking point following strong earnings and an optimistic long-term revenue outlook, which has been reinforced by a recent analyst upgrade. The community is abuzz with its strategic importance as a domestic foundry, focusing on quantum computing, aerospace, defense, and advanced packaging amid U.S. chip reshoring efforts. Investors are actively debating the company's significant growth potential, with many viewing recent price dips as prime opportunities.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to significant news, including its rumored acquisition of SkyWater Technology, its official inclusion in the Missile Defense Agency's SHIELD/Golden Dome initiative, and the strategic hiring of a former DOD CIO. The community is actively discussing these developments, viewing them as pivotal for IonQ's role in next-gen defense and a major step in the quantum computing race, amidst ongoing debates about its valuation and sector volatility.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp (UAMY) is trending following its acquisition of a critical minerals flotation facility, strategically enhancing its ability to process antimony and other valuable materials. The community is highly bullish, anticipating significant government investment, especially given the company's existing role as a sole-source antimony supplier for the US military. Investors see UAMY as a prime play in the critical minerals sector, comparing its potential to other recently-backed miners in a climate of increased demand.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is heavily discussed as the market anticipates key 3-year data from its pivotal ELEVIDYS gene therapy study, with community members debating whether the results will trigger a significant short squeeze or a "sell the news" reaction. Investors are also closely watching for updates on the company's broader gene therapy pipeline, including upcoming data from its siRNA programs for other rare neuromuscular diseases, amidst ongoing discussions about the stock's long-term valuation and high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exencial Wealth Advisors LLC Has $3.92 Million Position in OneMedNet Corporation $ONMD

Exencial Wealth Advisors LLC grew its position in OneMedNet Corporation (NASDAQ:ONMD - Free Report) by 141.3% in the third quarter, according to the company in its most recent 13F filing with the...

Short Interest in OneMedNet Corporation (NASDAQ:ONMD) Drops By 68.2%

OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) was the target of a significant decline in short interest in December. As of December 31st, there was short interest totaling 134,674 shares, a...

OneMedNet Corporation (NASDAQ:ONMD) Short Interest Update

OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totaling...

OneMedNet (NASDAQ:ONMD) CEO Aaron Green Sells 61,555 Shares

OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) CEO Aaron Green sold 61,555 shares of the firm's stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of...

Insider Selling: OneMedNet (NASDAQ:ONMD) CEO Sells 61,555 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) CEO Aaron Green sold 61,555 shares of the company's stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price...

OneMedNet (NASDAQ:ONMD) CEO Aaron Green Sells 64,767 Shares

OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) CEO Aaron Green sold 64,767 shares of the company's stock in a transaction that occurred on Wednesday, October 22nd. The stock was sold at an...

Insider Buying: OneMedNet (NASDAQ:ONMD) Insider Purchases 1,666,666 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) insider Jeffrey Yu acquired 1,666,666 shares of the firm's stock in a transaction that occurred on Friday, June 20th. The stock was acquired at...

OneMedNet (NASDAQ:ONMD) Insider Jeffrey Yu Buys 1,666,666 Shares

OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) insider Jeffrey Yu bought 1,666,666 shares of the company's stock in a transaction on Friday, June 20th. The shares were bought at an average...

Jeffrey Yu Buys 16,500 Shares of OneMedNet (NASDAQ:ONMD) Stock

OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) insider Jeffrey Yu bought 16,500 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was purchased at...

OneMedNet (NASDAQ:ONMD) Insider Jeffrey Yu Purchases 15,000 Shares

OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) insider Jeffrey Yu purchased 15,000 shares of OneMedNet stock in a transaction on Thursday, August 21st. The shares were acquired at an average...

OneMedNet Corp. designs and develops clinical imaging technology for the healthcare sector. It offers OneMedNet iRWD, a solution that securely de-identifies, searches, curates and shares medical images data with patients, care providers, and hospitals. The company was founded by Jeffrey N. Yu in 2009 and is headquartered in Eden Prairie, MN.

OneMedNet Corp. - Ordinary Shares - Class A

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Current Price	$0.9808
Prev Close	$0.967
Open	$0.99
Dividend Yield	0.00%
50-Day Moving Average	$1.32
Beta	0.51
Avg. Volume	631,299.27
PE Ratio	-12.74

52-Week High	$4.22
52-Week Low	$0.30
Market Capitalization	$50.21M
EPS (Annual)	-$0.3608
Price to Book	-12.38
Revenue Per Employee	$29,227.27
Enterprise Value/EBITDA	N/A

ONMD
OneMedNet Corp. - Ordinary Shares - Class A

Feed

News

Sentiment

Fundamentals

Info

Latest ONMD News

ONMDOneMedNet Corp. - Ordinary Shares - Class A